There is hope (and need) for male contraception

Linda Brent, PhD

Executive Director, Parsemus Foundation

Vasalgel and other new male contraceptives were highlighted in an article in The Telegraph. Written by Aaron Hamlin, the executive director of the Male Contraception Initiative, the piece offers hope that men and their partners will have more and better options for reproductive control in just a few years. The article points out that Vasalgel is poised to be the first approved male contraceptive since the condom. To stay up to date on Vasalgel’s development, sign up for our newsletters. Or consider a donation to Parsemus Foundation in support of Vasalgel.
We’re sorry, you are not eligible for the nationwide COVID-OUT or ACTIV-6 studies, but you may be eligible for other federal trials:

And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:

Trials Today